EUVIMEDEUVIMED entdecken
Crossref

Identifying Adverse Drug Withdrawal Events at Scale Using Electronic Clinical Data: Development, Adjudication, and Practical Challenges

Ariel R Green iD, Orla C Sheehan, Emily Reeve, Glenn K Goodrich, James Lagrotteria, Jennifer S Cook, Kathy S Gleason iD, Courtney R Kraus, Matthew L Maciejewski, Jonathan D Norton iD, Valerie Paolino, Linda A Weffald und 2 weitere

Journal of the American Geriatrics Society · 05.11.2026

DOI: 10.1111/jgs.70811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 05.11.2026. Verfasst von Ariel R Green und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Die Arbeit nennt 19 Literaturangaben. Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are no scalable, automated methods to identify adverse drug withdrawal events (ADWE) in deprescribing studies. We describe the development of a scalable approach to identifying potential ADWE using electronic clinical data, characterize the ADWE identified, and discuss complexities encountered.

Methods

We identified potential ADWE through two steps: (1) identifying intentional medication discontinuations; (2) applying diagnostic and procedure codes and clinical parameters suggestive of possible ADWE in specified risk timeframes. Discontinuations of five medication classes (oral diabetes medications, statins, bladder antimuscarinics, antihypertensives, and anticoagulants/antiplatelet agents) for adults age ≥ 65 enrolled with Kaiser Permanente Colorado (KPCO) were identified through text search and medication order data and confirmed through chart review. Electronically identified potential ADWE were manually adjudicated; notes made during adjudication were analyzed using qualitative content analysis to classify possible ADWE and characterize associated features.

Results

Within specific drug groups, between 51% (39/76 bladder antimuscarinics) and 81% (104/128 antihypertensives) were confirmed as intended discontinuations. Manual adjudication across all drug groups classified 60 of 293 events as possible ADWE, 23 probable, and 2 definite; 1 major ADWE resulted in hospitalization. Adjudication illuminated 5 challenges in classifying ADWE: (1) Causal Inference: unclear whether potential ADWE had a clear causal link to medication discontinuation given medical complexity; (2) Timeframe: event occurred outside expected risk window; (3) Contraindication: medication was intentionally held due to acute contraindication; resulting clinical changes were expected; (4) Terminology: medication had never been effective; symptoms were present both before and after discontinuation, and did not recur as a result of stopping drug; and (5) Intent: observed clinical change was intended or expected outcome of stopping medication.

Conclusions

Many potential ADWE may be expected or intended sequelae of appropriate clinical care, or unavoidable. Future research should define and validate ADWE. Broader terminology is required to avoid mislabeling expected consequences as ADWE.

Schlagwörter

Stichwörter der Autor:innen

adverse drug withdrawal eventsdeprescribingmedication discontinuationtext search

Autor:innen und Institutionen

  • Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • School of Pharmacy and Biomedical Science, Adelaide University, Adelaide, South Australia, Australia.
  • Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Veterans Affairs Medical Center, Durham, North Carolina, USA.

ORCID-Profile: Ariel R Green, Kathy S Gleason, Jonathan D Norton

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Green, A. R., Sheehan, O. C., Reeve, E., Goodrich, G. K., Lagrotteria, J., Cook, J. S., Gleason, K. S., Kraus, C. R., Maciejewski, M. L., Norton, J. D., Paolino, V., Weffald, L. A., Boyd, C. M., & Bayliss, E. A. (2026). Identifying Adverse Drug Withdrawal Events at Scale Using Electronic Clinical Data: Development, Adjudication, and Practical Challenges. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70811

Vancouver

Green AR, Sheehan OC, Reeve E, Goodrich GK, Lagrotteria J, Cook JS, et al. Identifying Adverse Drug Withdrawal Events at Scale Using Electronic Clinical Data: Development, Adjudication, and Practical Challenges. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70811

BibTeX
@article{Green2026,
  author = {Green, Ariel R and Sheehan, Orla C and Reeve, Emily and Goodrich, Glenn K and Lagrotteria, James and Cook, Jennifer S and Gleason, Kathy S and Kraus, Courtney R and Maciejewski, Matthew L and Norton, Jonathan D and Paolino, Valerie and Weffald, Linda A and Boyd, Cynthia M and Bayliss, Elizabeth A},
  title = {Identifying Adverse Drug Withdrawal Events at Scale Using Electronic Clinical Data: Development, Adjudication, and Practical Challenges},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  doi = {10.1111/jgs.70811}
}
Kostenlos starten →